Sunday, December 19, 2004

From Macleans:
News of Celebrex's increased heart risk leaves regulators scrambling
Health authorities were left scrambling Friday when the company that makes one of the world's most popular pain relievers admitted Celebrex appears to increase the risk of heart attack in users.

Pfizer Inc., which informed Health Canada of the finding Friday, announced it had no plans to pull the drug from the market, as competitor Merck did in September when it revealed Vioxx, another wildly popular drug in the same class, doubled users' risk of heart attack.

No comments: